Mark A. Meltz serves as Executive at Audentes Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mark A. Meltz has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 10, 2026 involved receiving (via award) 50,000 shares valued at $0.
Mark A. Meltz currently holds 50,000 shares of Audentes Therapeutics, Inc. (BOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Meltz has been a net neutral trader of BOLD stock. They have purchased $0 and sold $0 worth of shares.
Mark A. Meltz's most recent insider trade was on Feb 10, 2026, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 1, 2024 | KNTE | $1.4K | Payment | 558 | $2.59 | Discretionary |
| Dec 1, 2023 | KNTE | $1.2K | Payment | 541 | $2.25 | Discretionary |
| Sep 1, 2023 | KNTE | $1.3K | Payment | 541 | $2.35 | Discretionary |
| Jun 1, 2023 | KNTE | $2.3K | Payment | 541 | $4.30 | Discretionary |
| Mar 1, 2023 | KNTE | $3.3K | Payment | 638 | $5.21 | Discretionary |
| Dec 1, 2022 | KNTE | $4.2K | Payment | 541 | $7.75 | Discretionary |
| Sep 1, 2022 | KNTE | $0 | Award | 25,000 | $N/A | Discretionary |
| Jan 15, 2020 | BOLD | $2.0M | Tender | 32,705 | $60.00 | Discretionary |
| Dec 12, 2019 | BOLD | $274.8K | Payment | 4,628 | $59.37 | Discretionary |
| Mar 28, 2019 | BOLD | $0 | Award | 37,333 | $N/A | Discretionary |